| Date Filed | Type | Description |
| 06/15/2023 |
4
| Pellegrini Niamh Louise (Director) has filed a Form 4 on Acutus Medical, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 19,600 options to buy
@ $0.8349, valued at
$16.4k
|
|
| 05/31/2023 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 1,143 shares
@ $26.45, valued at
$30.2k
|
|
| 03/09/2023 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 39,282 shares
@ $0 |
|
| 03/06/2023 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 1,979 shares
@ $33.99, valued at
$67.3k
|
|
| 03/02/2023 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,718 shares
@ $31.44, valued at
$148.3k
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 300 shares
@ $161.96, valued at
$48.6k
Sold 450 shares
@ $160.715, valued at
$72.3k
Exercised 750 options to buy
@ $64.95, valued at
$48.7k
|
|
| 11/12/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 750 shares
@ $170.75, valued at
$128.1k
Exercised 750 options to buy
@ $64.95, valued at
$48.7k
|
|
| 10/26/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 1,817 shares
@ $165, valued at
$299.8k
|
|
| 10/21/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 1,000 shares
@ $155, valued at
$155k
|
|
| 10/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Sold 750 shares
@ $139.14, valued at
$104.4k
Exercised 750 options to buy
@ $64.95, valued at
$48.7k
|
|
| 08/10/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Paid exercise price by delivering 4,476 shares
@ $141.77, valued at
$634.6k
Sold 750 shares
@ $140.11, valued at
$105.1k
Exercised 750 options to buy
@ $64.95, valued at
$48.7k
|
|
| 03/04/2020 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 5,446 shares
@ $0 |
|
| 07/17/2019 |
4
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 4 on NEVRO CORP|
Txns:
| Granted 33,175 shares
@ $0
Granted 71,575 options to buy
@ $64.95, valued at
$4.6M
|
|
| 07/17/2019 |
3
| Pellegrini Niamh Louise (Chief Commercial Officer) has filed a Form 3 on NEVRO CORP |